Activation of the PI3K/Akt/mTOR signalling pathway has been shown to be an important risk factor for early recurrence and poor prognosis in HCC patients [36], as this signalling pathway can regulate cell cycle, survival, metabolism, invasion and angiogenesis. Here, AKT1 is linked to hepatocellular carcinoma.